Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1.

Fanconi anemia (FA) is a chromosomal instability disorder characterized by progressive bone marrow failure. Experimental evidence suggests that enhanced oxidant and myelosuppressive cytokine-mediated apoptosis of hematopoietic stem and progenitor cells contributes to the pathogenesis of marrow failure in FA. However, the molecular mechanisms responsible for the apoptotic phenotype in hematopoietic cells are incompletely understood. Recent data in Fancc-/- murine embryonic fibroblasts (MEFs) implicate increased oxidant-induced apoptotic signaling through the redox-dependent protein, apoptosis signal-regulating kinase 1 (Ask1). Here, we examined whether altered Ask1 signaling participated in the proapoptotic phenotype of primary Fancc-/- MEFs and hematopoietic progenitors treated with the myelosuppressive cytokine tumor necrosis factor-alpha (TNF-alpha). Our data indicate that TNF-alpha induces hyperactivation of Ask1 and the downstream effector p38 in Fancc-/- MEFs. In addition,Ask1 inactivation in Fancc-/- MEFs and hematopoietic progenitors restored survival to wild-type (WT) levels in the presence of TNF-alpha. Furthermore, targeting the Ask1 pathway by using either antioxidants or a p38 inhibitor protected Fancc-/- MEFs and c-kit+ cells from TNF-alpha-induced apoptosis. Collectively, these data argue that the predisposition of Fancc-/- hematopoietic progenitors to apoptosis is mediated in part through altered redox regulation and Ask1 hyperactivation.

[1]  Tak W. Mak,et al.  Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells , 2004, Nature.

[2]  Xiaoling Zhang,et al.  The Fanconi Anemia Proteins Functionally Interact with the Protein Kinase Regulated by RNA (PKR)* , 2004, Journal of Biological Chemistry.

[3]  Xiaxin Li,et al.  Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice. , 2004, Blood.

[4]  M. Saadatzadeh,et al.  Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic Pathway* , 2004, Journal of Biological Chemistry.

[5]  A. Venkitaraman.  Tracing the network connecting brca and fanconi anaemia proteins , 2004, Nature Reviews Cancer.

[6]  I. Fabian,et al.  The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. , 2004, Biochemical pharmacology.

[7]  H. Broxmeyer,et al.  Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. , 2003, Blood.

[8]  E. Vellenga,et al.  Constitutive cytoplasmic localization of p21Waf1/Cip1 affects the apoptotic process in monocytic leukaemia , 2003, Leukemia.

[9]  H. Youssoufian,et al.  Fanconi anaemia proteins: major roles in cell protection against oxidative damage. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  M. Peppelenbosch,et al.  Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. , 2003, Blood.

[11]  F. Jirik,et al.  Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. , 2003, Blood.

[12]  L. Platanias.  The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. , 2003, Pharmacology & therapeutics.

[13]  A. Chow,et al.  Single‐Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen‐Activated Protein Kinase Inhibitor: A First‐in‐Human Study , 2003, Journal of clinical pharmacology.

[14]  H. Broxmeyer,et al.  Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. , 2003, Blood.

[15]  G. Bagby,et al.  The Anti-apoptotic Function of Hsp70 in the Interferon-inducible Double-stranded RNA-dependent Protein Kinase-mediated Death Signaling Pathway Requires the Fanconi Anemia Protein, FANCC* , 2002, The Journal of Biological Chemistry.

[16]  M. Suntharalingam,et al.  Role of Glutaredoxin in Metabolic Oxidative Stress , 2002, The Journal of Biological Chemistry.

[17]  A. Verma,et al.  Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia1 , 2002, The Journal of Immunology.

[18]  H. Ichijo,et al.  Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. , 2002, Antioxidants & redox signaling.

[19]  T. van der Poll,et al.  Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia1 , 2002, The Journal of Immunology.

[20]  A. Verma,et al.  Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis* , 2002, The Journal of Biological Chemistry.

[21]  I. Dybedal,et al.  Self-Renewal of Multipotent Long-Term Repopulating Hematopoietic Stem Cells Is Negatively Regulated by FAS and Tumor Necrosis Factor Receptor Activation , 2001, The Journal of experimental medicine.

[22]  I. Dybedal,et al.  Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. , 2001, Blood.

[23]  S. Olson,et al.  The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. , 2001, Blood.

[24]  M. Buchwald,et al.  Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. , 2001, Blood.

[25]  G. Bagby,et al.  FANCC interacts with Hsp70 to protect hematopoietic cells from IFN‐γ/TNF‐α‐mediated cytotoxicity , 2001 .

[26]  M. Buchwald,et al.  Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1 , 2001, Nature Medicine.

[27]  Hans Joenje,et al.  The emerging genetic and molecular basis of Fanconi anaemia , 2001, Nature Reviews Genetics.

[28]  K. Kang,et al.  Glutathione S-Transferase Mu Modulates the Stress-activated Signals by Suppressing Apoptosis Signal-regulating Kinase 1* , 2001, The Journal of Biological Chemistry.

[29]  S. Fagerlie,et al.  Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. , 2001, Blood.

[30]  T Takahashi,et al.  ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis , 2001, EMBO reports.

[31]  Rekha C. Patel,et al.  PACT, a Stress-modulated Cellular Activator of Interferon-induced Double-stranded RNA-activated Protein Kinase, PKR* , 2000, The Journal of Biological Chemistry.

[32]  B. Williams,et al.  The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin , 2000, The EMBO journal.

[33]  A. Berns,et al.  Mice with a targeted disruption of the Fanconi anemia homolog Fanca. , 2000, Human molecular genetics.

[34]  S. Fagerlie,et al.  The Fanconi Anemia Protein FANCC Binds to and Facilitates the Activation of STAT1 by Gamma Interferon and Hematopoietic Growth Factors , 2000, Molecular and Cellular Biology.

[35]  M. Montalto,et al.  Posttranscriptional cell cycle-dependent regulation of human FANCC expression. , 2000, Blood.

[36]  N. Young.  Bone Marrow Failure Syndromes , 2000 .

[37]  S. Lazo-Kallanian,et al.  Essential Role for the P55 Tumor Necrosis Factor Receptor in Regulating Hematopoiesis at a Stem Cell Level , 1999, The Journal of experimental medicine.

[38]  M. Buchwald,et al.  Loss of FancC Function Results in Decreased Hematopoietic Stem Cell Repopulating Ability , 1999, Blood.

[39]  Jon C. Aster,et al.  Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow , 1998 .

[40]  Johnson M Liu,et al.  Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. , 1998, Blood.

[41]  M. Buchwald,et al.  Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. , 1998, Blood.

[42]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[43]  J. Boss,et al.  Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB , 1997, Molecular and cellular biology.

[44]  Gordon Royle,et al.  Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. , 1997, Blood.

[45]  N. Young,et al.  The pathophysiology of acquired aplastic anemia. , 1997, The New England journal of medicine.

[46]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[47]  R. Braun,et al.  Germ cell defects and hematopoietic hypersensitivity to gamma- interferon in mice with a targeted disruption of the Fanconi anemia C gene , 1996 .

[48]  H. Youssoufian.  Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  A. D’Andrea,et al.  The Fanconi anaemia/BRCA pathway , 2003, Nature Reviews Cancer.

[50]  J. Liu.  Fanconi's anemia. , 2000 .

[51]  F. Oski,et al.  Hematology of Infancy and Childhood , 1974 .